Thomas (tc) Chan - 15 Sep 2026 Form 4 Insider Report for GoodRx Holdings, Inc. (GDRX)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
15 Sep 2026, 16:05:31 UTC
Prior SEC filing
17 Aug 2026
Next SEC filing
15 Oct 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Gracye Cheng, Attorney-in-Fact for Thomas (TC) Chan

Key filing fact

Thomas (tc) Chan filed Form 4 for GoodRx Holdings, Inc. (GDRX) on 15 Sep 2026.

Key facts

  • This page summarizes Thomas (tc) Chan's Form 4 filing for GoodRx Holdings, Inc. (GDRX).
  • 3 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 15 Sep 2026, 16:05.

Change

  • Previous filing in this sequence was filed on 17 Aug 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002131829 Primary reporting owner

Chan Thomas (TC)

Relationship
Chief Accounting Officer
Address
C/O GOODRX HOLDINGS, INC., 2701 OLYMPIC BOULEVARD, SANTA MONICA
Signature
/s/ Gracye Cheng, Attorney-in-Fact for Thomas (TC) Chan
Signature date
15 Sep 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

GDRX transaction

Class A Common Stock

Options Exercise

Transaction value
Shares
+2,101
Change %
+16%
Price
Shares after
15,647
Date
15 Sep 2026
Ownership
Direct
Footnotes
F1
GDRX transaction

Class A Common Stock

Tax liability

Transaction value
Shares
-1,069
Change %
-6.8%
Price
$3.56*
Shares after
14,578
Date
15 Sep 2026
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

GDRX transaction Derivative

Restricted Stock Unit

Options Exercise

Transaction value
Shares
-2,101
Change %
-14%
Price
$0.000000*
Shares after
12,606
Date
15 Sep 2026
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount
2,101
Exercise price
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

Footnote F2

This restricted stock units award vests with respect to 1/16 of the award in quarterly installments on June 15, 2024 and on each quarterly anniversary thereafter, subject to the Reporting Person's continued service through each applicable vesting date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .